Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

A reliable method was developed to measure perospirone levels in human plasma for clinical use.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Higher PSA levels can indicate prostate cancer, but there's overlap with non-cancerous conditions.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Both single and double spin PRP methods effectively treat male hair loss, but single spin is easier and cheaper.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Finasteride helps with prostate symptoms but may cause sexual side effects.

The method accurately measures finasteride in skin after using special carriers.

The journal retracted an article due to inaccurate statistics and asked the authors to revise and resubmit it.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Using both vertical and transverse sections for alopecia biopsies improves diagnosis without extra cost.

Treatments for enlarged prostate can cause problems with ejaculation, and less invasive options might preserve sexual function better.

PICAT is a reliable tool for assessing dermatology residents' skills in PRP procedures for hair loss.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

WS PRO 160 I 120 mg effectively treats urinary symptoms from BPH with good safety and tolerability.

Hair follicles and urine cell pellets are promising for transcriptome studies due to consistent quality and useful expression profiles.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

New method measures finasteride in blood quickly and accurately.

The modified wash test is better than TrichoScan® for diagnosing hair loss.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Combining medications is more effective for treating benign prostatic syndrome symptoms.

The cross beam laser is a useful tool for safely measuring scalp stretchiness to improve hair transplant results.